Excerpt
Dr Harpal Kumar, Cancer Research UK's chief executive, said: ‘Over the past year, thousands of lives have been saved through improved cancer treatments, earlier detection and effective health awareness campaigns.
‘Over the coming year, we will review two hard-to-treat cancers - oesophageal and pancreatic cancer - to identify research that may help to prevent, diagnose or treat these diseases in the future.’
Cancer Research UK funds over 4,250 research scientists, doctors and nurses throughout the UK. The charity aims to increase its research expenditure to £400m by 2010 to continue this vital work. ‘The process of scientific research is hugely expensive but it is more than worth the investment. The improved survival rates we are now seeing for many types of cancer are proof that cancer research delivers results’, added Dr Kumar.
The Charity's success was to a large part made possible by strong fundraising efforts. In the Charity's flagship Race for Life women-only series of 5km runs, some 740,000 women took part, raising £59 million. In addition, one third of the research funding came from legacies left to the charity and over half came from small gifts and regular donations.
Cancer Research UK was formed in 2002 from the merger of the Cancer Research Campaign and Imperial Cancer Research Fund. When the charity was formed it was spending around £160m per annum on research.
A full copy of the Annual Report and Accounts is available on request, and the Charity's Annual Review, Annual Report and Accounts and Scientific Yearbook are available in electronic formats at: www.cancerresearchuk.